Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Fusion | 10 | 2023 | 518 | 1.880 |
Why?
|
| Lumbar Vertebrae | 7 | 2021 | 490 | 1.690 |
Why?
|
| Neurosurgery | 2 | 2023 | 50 | 1.310 |
Why?
|
| Cervical Vertebrae | 10 | 2023 | 352 | 1.270 |
Why?
|
| Neurosurgical Procedures | 6 | 2016 | 152 | 1.220 |
Why?
|
| Intervertebral Disc Degeneration | 2 | 2020 | 117 | 1.140 |
Why?
|
| Minimally Invasive Surgical Procedures | 5 | 2021 | 303 | 1.130 |
Why?
|
| Intervertebral Disc | 3 | 2019 | 217 | 1.110 |
Why?
|
| Allostasis | 1 | 2023 | 5 | 0.910 |
Why?
|
| Spinal Cord Neoplasms | 3 | 2016 | 34 | 0.710 |
Why?
|
| Asymptomatic Diseases | 1 | 2020 | 18 | 0.710 |
Why?
|
| Humans | 40 | 2023 | 29855 | 0.660 |
Why?
|
| Decompression, Surgical | 3 | 2017 | 144 | 0.650 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 285 | 0.610 |
Why?
|
| Vertebral Artery | 1 | 2017 | 5 | 0.590 |
Why?
|
| Postoperative Complications | 5 | 2023 | 957 | 0.580 |
Why?
|
| Paraparesis | 1 | 2016 | 1 | 0.560 |
Why?
|
| Spondylosis | 2 | 2022 | 32 | 0.560 |
Why?
|
| Treatment Outcome | 15 | 2023 | 3561 | 0.560 |
Why?
|
| Scoliosis | 1 | 2017 | 35 | 0.560 |
Why?
|
| Meningeal Neoplasms | 1 | 2016 | 14 | 0.550 |
Why?
|
| Male | 29 | 2023 | 15870 | 0.550 |
Why?
|
| Multiple Myeloma | 1 | 2016 | 30 | 0.550 |
Why?
|
| Radiculopathy | 1 | 2017 | 62 | 0.540 |
Why?
|
| Abscess | 1 | 2016 | 26 | 0.540 |
Why?
|
| Female | 27 | 2023 | 16429 | 0.540 |
Why?
|
| Epidural Abscess | 1 | 2016 | 7 | 0.540 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2016 | 19 | 0.540 |
Why?
|
| Spinal Cord Compression | 1 | 2016 | 31 | 0.530 |
Why?
|
| Spinal Cord Diseases | 1 | 2016 | 52 | 0.530 |
Why?
|
| Perioperative Care | 1 | 2016 | 53 | 0.520 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 778 | 0.520 |
Why?
|
| Collagen | 1 | 2015 | 102 | 0.510 |
Why?
|
| Middle Aged | 19 | 2022 | 9962 | 0.510 |
Why?
|
| Spinal Neoplasms | 2 | 2014 | 36 | 0.500 |
Why?
|
| Spinal Fractures | 2 | 2015 | 62 | 0.480 |
Why?
|
| Head | 1 | 2014 | 23 | 0.470 |
Why?
|
| Professional Competence | 1 | 2014 | 39 | 0.470 |
Why?
|
| Adult | 15 | 2023 | 8748 | 0.470 |
Why?
|
| General Surgery | 1 | 2014 | 49 | 0.460 |
Why?
|
| Indocyanine Green | 1 | 2013 | 3 | 0.450 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2013 | 4 | 0.450 |
Why?
|
| Angiography | 1 | 2013 | 39 | 0.440 |
Why?
|
| Monitoring, Intraoperative | 1 | 2013 | 37 | 0.440 |
Why?
|
| Thoracic Vertebrae | 2 | 2011 | 112 | 0.420 |
Why?
|
| Ilium | 1 | 2012 | 31 | 0.420 |
Why?
|
| Myenteric Plexus | 3 | 2010 | 4 | 0.410 |
Why?
|
| Chordoma | 1 | 2011 | 9 | 0.390 |
Why?
|
| Osteotomy | 1 | 2012 | 164 | 0.380 |
Why?
|
| Internship and Residency | 1 | 2014 | 213 | 0.370 |
Why?
|
| Axis, Cervical Vertebra | 1 | 2010 | 9 | 0.370 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2019 | 1247 | 0.360 |
Why?
|
| Retrospective Studies | 8 | 2023 | 3325 | 0.350 |
Why?
|
| Cauda Equina | 2 | 2006 | 7 | 0.330 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 117 | 0.320 |
Why?
|
| Laryngoscopy | 3 | 2017 | 21 | 0.310 |
Why?
|
| Aged | 12 | 2021 | 9620 | 0.300 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2019 | 77 | 0.300 |
Why?
|
| Orthopedic Procedures | 1 | 2011 | 322 | 0.300 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2021 | 384 | 0.290 |
Why?
|
| Odontoid Process | 2 | 2017 | 10 | 0.280 |
Why?
|
| Neurons | 3 | 2010 | 380 | 0.280 |
Why?
|
| Elastic Tissue | 1 | 2006 | 1 | 0.270 |
Why?
|
| Intubation, Intratracheal | 2 | 2017 | 78 | 0.260 |
Why?
|
| Aging | 1 | 2015 | 1630 | 0.260 |
Why?
|
| Diskectomy | 3 | 2022 | 195 | 0.250 |
Why?
|
| Atlanto-Axial Joint | 2 | 2015 | 18 | 0.250 |
Why?
|
| Biomarkers | 2 | 2020 | 704 | 0.240 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 4930 | 0.230 |
Why?
|
| Age Factors | 2 | 2017 | 854 | 0.230 |
Why?
|
| Colon | 1 | 2004 | 149 | 0.220 |
Why?
|
| Pulmonary Edema | 1 | 2003 | 18 | 0.220 |
Why?
|
| Mental Health | 2 | 2021 | 105 | 0.220 |
Why?
|
| Lordosis | 1 | 2023 | 42 | 0.210 |
Why?
|
| Cadaver | 5 | 2017 | 362 | 0.200 |
Why?
|
| Spinal Curvatures | 1 | 2020 | 13 | 0.190 |
Why?
|
| Cohort Studies | 4 | 2021 | 1953 | 0.180 |
Why?
|
| Motivation | 1 | 2020 | 101 | 0.180 |
Why?
|
| Collagen Type IV | 1 | 2019 | 4 | 0.170 |
Why?
|
| Quality of Life | 2 | 2021 | 677 | 0.170 |
Why?
|
| Spinal Diseases | 1 | 2021 | 150 | 0.170 |
Why?
|
| Collagen Type II | 1 | 2019 | 33 | 0.170 |
Why?
|
| Motion | 2 | 2016 | 23 | 0.170 |
Why?
|
| Length of Stay | 1 | 2021 | 320 | 0.160 |
Why?
|
| Brain Neoplasms | 2 | 2014 | 134 | 0.160 |
Why?
|
| Patient Satisfaction | 1 | 2021 | 297 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 221 | 0.160 |
Why?
|
| Esophagus | 2 | 2010 | 59 | 0.160 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 411 | 0.160 |
Why?
|
| Finite Element Analysis | 1 | 2017 | 44 | 0.150 |
Why?
|
| Young Adult | 2 | 2016 | 1969 | 0.150 |
Why?
|
| Spinal Injuries | 1 | 2017 | 28 | 0.150 |
Why?
|
| Range of Motion, Articular | 2 | 2017 | 707 | 0.140 |
Why?
|
| Fatal Outcome | 1 | 2016 | 60 | 0.140 |
Why?
|
| Fractures, Bone | 1 | 2017 | 75 | 0.140 |
Why?
|
| Neurosurgeons | 1 | 2016 | 9 | 0.140 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 399 | 0.130 |
Why?
|
| Cost Savings | 1 | 2016 | 35 | 0.130 |
Why?
|
| Intubation | 1 | 2015 | 6 | 0.130 |
Why?
|
| Accidental Falls | 1 | 2017 | 117 | 0.130 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 66 | 0.130 |
Why?
|
| Larynx | 1 | 2015 | 16 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 40 | 0.130 |
Why?
|
| Organ Transplantation | 1 | 2016 | 37 | 0.130 |
Why?
|
| Recurrence | 1 | 2016 | 355 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 75 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2016 | 68 | 0.130 |
Why?
|
| Atlanto-Occipital Joint | 1 | 2015 | 18 | 0.130 |
Why?
|
| Prognosis | 2 | 2016 | 874 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2016 | 124 | 0.120 |
Why?
|
| Glioma, Subependymal | 1 | 2014 | 5 | 0.120 |
Why?
|
| Neural Tube Defects | 2 | 2006 | 9 | 0.120 |
Why?
|
| Neurilemmoma | 1 | 2014 | 16 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2016 | 332 | 0.120 |
Why?
|
| Hypothermia, Induced | 1 | 2014 | 22 | 0.120 |
Why?
|
| Medical Errors | 1 | 2014 | 28 | 0.120 |
Why?
|
| Papilloma, Choroid Plexus | 1 | 2014 | 2 | 0.120 |
Why?
|
| Cerebellopontine Angle | 1 | 2014 | 5 | 0.120 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 48 | 0.120 |
Why?
|
| Embolism, Fat | 1 | 2013 | 1 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2014 | 154 | 0.110 |
Why?
|
| Intracranial Pressure | 1 | 2013 | 21 | 0.110 |
Why?
|
| Video Recording | 1 | 2013 | 47 | 0.110 |
Why?
|
| Time Factors | 2 | 2010 | 1641 | 0.110 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2014 | 121 | 0.110 |
Why?
|
| Seizures | 1 | 2013 | 88 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2014 | 286 | 0.110 |
Why?
|
| Brain Diseases | 1 | 2013 | 83 | 0.110 |
Why?
|
| Inflammation | 1 | 2015 | 347 | 0.110 |
Why?
|
| Microsurgery | 1 | 2012 | 40 | 0.100 |
Why?
|
| Benzophenones | 2 | 2022 | 27 | 0.100 |
Why?
|
| Rats, Wistar | 3 | 2010 | 45 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2012 | 230 | 0.100 |
Why?
|
| Polymers | 2 | 2022 | 40 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 1859 | 0.100 |
Why?
|
| Polyethylene Glycols | 2 | 2022 | 58 | 0.100 |
Why?
|
| Joint Instability | 1 | 2015 | 389 | 0.090 |
Why?
|
| Protein Deficiency | 1 | 2010 | 1 | 0.090 |
Why?
|
| Rats | 3 | 2010 | 876 | 0.090 |
Why?
|
| Biomechanical Phenomena | 3 | 2016 | 680 | 0.080 |
Why?
|
| Bone Screws | 1 | 2010 | 181 | 0.080 |
Why?
|
| Pain Measurement | 2 | 2021 | 468 | 0.080 |
Why?
|
| Histocytochemistry | 2 | 2007 | 26 | 0.080 |
Why?
|
| Serratia marcescens | 1 | 2007 | 11 | 0.080 |
Why?
|
| Serratia Infections | 1 | 2007 | 10 | 0.080 |
Why?
|
| Brain Abscess | 1 | 2007 | 7 | 0.080 |
Why?
|
| Diseases in Twins | 1 | 2007 | 8 | 0.080 |
Why?
|
| Diet, Protein-Restricted | 1 | 2007 | 3 | 0.070 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2007 | 10 | 0.070 |
Why?
|
| Craniocerebral Trauma | 2 | 2004 | 11 | 0.070 |
Why?
|
| Laryngoscopes | 2 | 2016 | 7 | 0.070 |
Why?
|
| Colostomy | 1 | 2004 | 2 | 0.060 |
Why?
|
| NADP | 1 | 2004 | 9 | 0.060 |
Why?
|
| NAD | 1 | 2004 | 7 | 0.060 |
Why?
|
| Adolescent | 1 | 2010 | 2334 | 0.060 |
Why?
|
| Cell Count | 1 | 2004 | 97 | 0.060 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2004 | 4 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2004 | 327 | 0.060 |
Why?
|
| Child Abuse | 1 | 2004 | 36 | 0.060 |
Why?
|
| Hemophilia A | 1 | 2004 | 42 | 0.060 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2003 | 9 | 0.060 |
Why?
|
| Autonomic Nervous System | 1 | 2003 | 23 | 0.050 |
Why?
|
| Neck | 1 | 2023 | 34 | 0.050 |
Why?
|
| Headache | 1 | 2003 | 43 | 0.050 |
Why?
|
| Animals | 3 | 2010 | 4640 | 0.050 |
Why?
|
| Ketones | 1 | 2022 | 20 | 0.050 |
Why?
|
| Acute Disease | 1 | 2003 | 225 | 0.050 |
Why?
|
| Convalescence | 1 | 2020 | 7 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2021 | 127 | 0.050 |
Why?
|
| Leg | 1 | 2020 | 49 | 0.050 |
Why?
|
| Critical Care | 1 | 2003 | 242 | 0.040 |
Why?
|
| Back Pain | 1 | 2020 | 63 | 0.040 |
Why?
|
| Minimal Clinically Important Difference | 1 | 2021 | 106 | 0.040 |
Why?
|
| Allografts | 1 | 2021 | 180 | 0.040 |
Why?
|
| NADPH Dehydrogenase | 2 | 2010 | 7 | 0.040 |
Why?
|
| Acetylcholinesterase | 2 | 2010 | 6 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2017 | 12 | 0.040 |
Why?
|
| Pregnancy | 2 | 2010 | 388 | 0.040 |
Why?
|
| Pain | 1 | 2020 | 397 | 0.040 |
Why?
|
| Supine Position | 1 | 2016 | 15 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1823 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2016 | 54 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 803 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 678 | 0.030 |
Why?
|
| Syndrome | 1 | 2013 | 88 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2013 | 66 | 0.030 |
Why?
|
| Femoral Fractures | 1 | 2013 | 42 | 0.030 |
Why?
|
| Disease Management | 1 | 2013 | 122 | 0.030 |
Why?
|
| Dietary Proteins | 1 | 2010 | 22 | 0.020 |
Why?
|
| Thienamycins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Amikacin | 1 | 2007 | 7 | 0.020 |
Why?
|
| Dihydrolipoamide Dehydrogenase | 1 | 2007 | 2 | 0.020 |
Why?
|
| Weaning | 1 | 2007 | 5 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 29 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 364 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2007 | 618 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 401 | 0.020 |
Why?
|
| Survival Rate | 1 | 2004 | 376 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 498 | 0.010 |
Why?
|
| Infant | 1 | 2004 | 542 | 0.010 |
Why?
|